Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-01-31 4:15 pm Sale | 2025-01-31 | 13D | Repare Therapeutics Inc. RPTX | MPM BioVentures 2014, L.P. | 1,941,242 4.600% | -208,173![]() (-9.69%) | Filing History |
2025-01-15 6:43 pm Sale | 2025-01-13 | 13D | Repare Therapeutics Inc. RPTX | MPM BioVentures 2014, L.P. | 2,149,415 5.100% | -509,117![]() (-19.15%) | Filing History |
2025-01-06 4:49 pm Sale | 2025-01-02 | 13D | Repare Therapeutics Inc. RPTX | MPM BioVentures 2014, L.P. | 2,658,532 6.300% | -642,324![]() (-19.46%) | Filing History |
2024-12-26 4:34 pm Sale | 2024-12-20 | 13D | Repare Therapeutics Inc. RPTX | MPM BioVentures 2014, L.P. | 3,300,856 7.800% | -581,629![]() (-14.98%) | Filing History |
2024-11-14 9:00 pm Sale | 2024-09-30 | 13G | Repare Therapeutics Inc. RPTX | Redmile Group LLC | 1,942,555 4.600% | -206,193![]() (-9.60%) | Filing History |
2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | Repare Therapeutics Inc. RPTX | Blue Owl Capital Holdings LP | 3,372,499 7.930% | 250,000![]() (+8.01%) | Filing History |
2024-11-14 09:42 am Sale | 2024-09-30 | 13G | Repare Therapeutics Inc. RPTX | Deep Track Capital, LP | 0 0.000% | -2,992,731![]() (Position Closed) | Filing History |
2024-02-14 9:02 pm Purchase | 2023-12-31 | 13G | Repare Therapeutics Inc. RPTX | Blue Owl Capital Holdings LP | 3,122,499 7.410% | 3,122,499![]() (New Position) | Filing History |
2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | Repare Therapeutics Inc. RPTX | Redmile Group LLC | 2,148,748 5.100% | -535,648![]() (-19.95%) | Filing History |
2024-02-14 08:54 am Purchase | 2023-12-31 | 13G | Repare Therapeutics Inc. RPTX | Deep Track Capital, LP | 2,992,731 7.100% | 265,125![]() (+9.72%) | Filing History |
2024-01-29 4:01 pm Purchase | 2023-12-31 | 13G | Repare Therapeutics Inc. RPTX | ARK Investment Management LLC | 2,821,560 6.700% | 393,505![]() (+16.21%) | Filing History |
2023-11-17 4:52 pm Purchase | 2023-11-15 | 13D | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 10,333,600 24.500% | 1,235,000![]() (+13.57%) | Filing History |
2023-11-03 5:20 pm Purchase | 2023-11-02 | 13D | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 9,098,600 21.600% | 806,612![]() (+9.73%) | Filing History |
2023-02-14 4:29 pm Sale | 2022-12-31 | 13G | Repare Therapeutics Inc. RPTX | Redmile Group LLC | 2,684,396 6.400% | -105,100![]() (-3.77%) | Filing History |
2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | Repare Therapeutics Inc. RPTX | T. Rowe Price Associates, Inc. | 26,894 0.100% | -2,139,928![]() (-98.76%) | Filing History |
2023-02-14 08:57 am Purchase | 2022-12-31 | 13G | Repare Therapeutics Inc. RPTX | Deep Track Capital, LP | 2,727,606 6.500% | 627,606![]() (+29.89%) | Filing History |
2023-02-13 5:55 pm Purchase | 2022-12-31 | 13G | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 8,291,988 19.800% | 150,000![]() (+1.84%) | Filing History |
2023-02-13 12:07 pm Purchase | 2022-12-31 | 13G | Repare Therapeutics Inc. RPTX | CHI Advisors LLC | 2,800,126 6.670% | 587,870![]() (+26.57%) | Filing History |
2023-02-10 2:05 pm Sale | 2022-12-31 | 13G | Repare Therapeutics Inc. RPTX | ARK Investment Management LLC | 2,428,055 5.790% | -552,781![]() (-18.54%) | Filing History |
2023-02-09 12:31 pm Sale | 2023-02-09 | 13G | Repare Therapeutics Inc. RPTX | FMR LLC | 876,178 2.088% | -2,145,135![]() (-71.00%) | Filing History |